Stimulation index for PCNA mRNA in peripheral blood as immune function monitoring after renal transplantation

Transplantation

Volumn 87, Issue 9, 2009, Pages 1411-1414

  Niwa, Misao ^a   Miwa, Yuko ^a   Kuzuya, Takafumi ^a   Iwasaki, Kenta ^a   Haneda, Masataka ^a   Ueki, Tsuneo ^b   Katayama, Akio ^b   Hiramitsu, Takahisa ^c   Goto, Norihiko ^c   Nagasaka, Takaharu ^c   Watarai, Yoshihiko ^c   Uchida, Kazuharu ^c   Nakao, Akimasa ^a   Kobayashi, Takaaki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Masuko Memorial Hospital   (Japan)

^c NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Immune monitoring; Kidney transplantation; Proliferating cell nuclear antigen; Real time RT PCR

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; CYCLOSPORIN A; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHORBOL 13 ACETATE 12 MYRISTATE; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DRUG EFFICACY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; NUCLEOTIDE SEQUENCE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS REACTIVATION;

GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MONITORING, PHYSIOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER;

EID: 67649580485     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a277bb     Document Type: Article

References (17)

1. Böhler T, Nolting J, Kamar N, et al. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther Drug Monit 2007; 29: 77.
2. Barten MJ, Tarnok A, Garbade J, et al. Pharmacodynamics of T-cell function for monitoring immunosuppression. Cell Prolif 2007; 40: 50.
3. Weimert NA, Derotte M, Alloway RR, et al. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: Potential clinical implications. Ther Drug Monit 2007; 29: 141.
4. Sommerer C, Konstandin M, Dengler T, et al. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation 2006; 82: 1280.
5. Koefoed-Nielsen PB, Karamperis N, Højskov C, et al. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients. Transpl Int 2006; 19: 821.
6. Truong DQ, Darwish AA, Gras J, et al. Immunological monitoring after organ transplantation: Potential role of soluble CD30 blood level measurement. Transpl Immunol 2007; 17: 283.
7. Korin YD, Lee C, Gjertson DW, et al. A novel flow assay for the detection of cytokine secreting alloreactive T cells: Application to immune monitoring. Hum Immunol 2005; 66: 1110.
8. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77.
9. Israeli M, Yussim A, Mor E, et al. Preceeding the rejection: In search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007; 18: 7.
10. Couzi L, Thie'baut R, Carron JC, et al. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. Transplantation 2008; 86: 1060.
11. Kurki P, Lotz M, Ogata K, et al. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987; 138: 4114.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402.
13. Mitchell BS, Dayton JS, Turka LA, et al. IMP dehydrogenase inhibitors as immunomodulators. Ann N Y Acad Sci 1993; 685: 217.
14. Najafian N, Albin MJ, Newell KA. How can we measure immunologic tolerance in humans? J Am Soc Nephrol 2006; 17: 2652.
15. Ashton-Chess J, Giral M, Soulillou JP, et al. Can immune monitoring help to minimize immunosuppression in kidney transplantation? Transpl Int 2009; 22: 110.
16. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 66.
17. Bhorade SM, Janata K, Vigneswaran WT, et al. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990.